Elekta (EKTA B) Stock Overview
A medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
EKTA B Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Elekta AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 54.30 |
| 52 Week High | SEK 66.70 |
| 52 Week Low | SEK 40.64 |
| Beta | 0.95 |
| 1 Month Change | -2.78% |
| 3 Month Change | -10.47% |
| 1 Year Change | 7.10% |
| 3 Year Change | -36.68% |
| 5 Year Change | -54.60% |
| Change since IPO | 297.32% |
Recent News & Updates
Narrative Update • Jun 01
EKTA B: Transformation Progress And Cost Savings Will Support Medium Term Upside
Analysts have lifted their fair value estimate for Elekta from about SEK 87 to roughly SEK 93. This reflects updated assumptions around discount rates, revenue growth, margins and a higher future P/E, even as recent Street research has shifted the stock toward more Hold-oriented ratings with price targets around SEK 58 to SEK 60.Analysis Article • May 31
Results: Elekta AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts
There's been a notable change in appetite for Elekta AB (publ) ( STO:EKTA B ) shares in the week since its full-year...Recent updates
Narrative Update • Jun 01
EKTA B: Transformation Progress And Cost Savings Will Support Medium Term Upside
Analysts have lifted their fair value estimate for Elekta from about SEK 87 to roughly SEK 93. This reflects updated assumptions around discount rates, revenue growth, margins and a higher future P/E, even as recent Street research has shifted the stock toward more Hold-oriented ratings with price targets around SEK 58 to SEK 60.Analysis Article • May 31
Results: Elekta AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts
There's been a notable change in appetite for Elekta AB (publ) ( STO:EKTA B ) shares in the week since its full-year...
Narrative Update • May 01
EKTA B: Heightened Execution Risks Will Challenge Higher P E Assumptions
Analysts have lifted their price target on Elekta to SEK 60, up SEK 11 from SEK 49, as they balance more cautious views from some firms with updated assumptions on growth, margins and the stock's future P/E. Analyst Commentary Recent research reflects a mixed but cautious stance on Elekta, with some bearish analysts tempering optimism around the higher SEK 60 price target.Narrative Update • Apr 16
EKTA B: Execution Setbacks Will Pressure Earnings Despite Higher Market Optimism
Narrative update on Elekta Analysts have lifted the average price target for Elekta to SEK 60 from SEK 49, reflecting mixed views where some now see a higher justified P/E multiple while others are turning more cautious on the shares. Analyst Commentary Recent research shows that while some analysts are comfortable with Elekta around SEK 60, others are turning more cautious and highlighting downside risks if execution or growth does not support the implied P/E multiple.
Narrative Update • Apr 02
EKTA B: Future Outlook Balances Mixed Ratings With Product Adoption Progress
Analysts lifted their fair value estimate for Elekta to SEK 58.27 from SEK 56.77, reflecting a higher assumed future P/E and recent Street research, where one firm raised its price target to SEK 60 while another turned more cautious on the shares. Analyst Commentary Bullish Takeaways Bullish analysts see the higher SEK 60 price target as better aligned with the updated fair value estimate, which now builds in a higher assumed P/E multiple.Narrative Update • Mar 19
EKTA B: Rising Margin Outlook And New Clearance Will Support Medium Term Upside
Analysts have nudged their price targets for Elekta higher, with one recent move taking the target to SEK 60 from SEK 49. This reflects updated views on fair value, discount rates, profit margins and future P/E assumptions.Narrative Update • Mar 04
EKTA B: New Radiotherapy Clearance And Adoption Will Support Medium Term Upside
Analysts have slightly increased their price target for Elekta to SEK 89.31 from SEK 88.60, reflecting updated assumptions around revenue growth, profit margins and the discount rate applied in their valuation work. What's in the News Elekta has scheduled an Analyst and Investor Day to discuss detailed financial plans and targets, providing additional insight into the company’s medium term priorities and capital allocation focus (Key Developments).Narrative Update • Feb 17
EKTA B: FX And Tariffs Will Continue To Pressure Future Earnings
Analysts have maintained their Elekta price target at SEK 39.0. Slightly updated assumptions around discount rate, revenue growth, profit margin and future P/E support this unchanged view. What's in the News Elekta plans an Analyst and Investor Day focused on detailed financial plans and company targets (Key Developments).Narrative Update • Feb 03
EKTA B: U.S. Clearance For New Radiotherapy System Will Support Earnings Outlook
Analysts have modestly lifted their price target on Elekta, citing updated assumptions that include a fair value of €88.60 compared with €86.58 previously, a slightly higher discount rate, marginally stronger revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Elekta announced that its Elekta Evo CT Linac system has received 510(k) clearance from the U.S. Food and Drug Administration, making the system available to radiation oncology professionals in the United States (Key Developments).Narrative Update • Jan 20
EKTA B: FX And Tariffs Will Continue To Pressure Future Earnings
Analysts have maintained their fair value estimate for Elekta at €39.0. Only modest adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions support an unchanged view on the stock’s long term pricing power and earnings potential. What's in the News Elekta Evo CT-Linac received 510(k) clearance from the U.S. Food and Drug Administration, making the system available to radiation oncology professionals in the United States (Key Developments).Analysis Article • Jan 17
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 11th of March...Analysis Article • Jan 12
Elekta AB (publ) (STO:EKTA B) Shares Could Be 48% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Elekta is kr115 based on 2 Stage Free Cash Flow to Equity Elekta is estimated...Narrative Update • Jan 05
EKTA B: Earnings Headwinds From FX And Tariffs Will Persist
Analysts have maintained their price target for Elekta at €39.00, making only modest adjustments to assumptions on discount rate, revenue growth, profit margin and future P/E. These changes consolidate their existing view rather than signaling a major shift in outlook.Narrative Update • Dec 16
EKTA B Risks Persist As Tariffs And Currency Pressures Likely To Deepen
Analysts have raised their price target on Elekta by approximately SEK 5 to SEK 39, reflecting expectations for stronger revenue growth and improved profit margins. What's in the News Elekta reiterated its full year 2025/26 outlook, expecting net sales in constant currency to grow year over year, while warning that current foreign exchange rates and tariffs will continue to weigh on earnings (company guidance).Analysis Article • Dec 07
Market Participants Recognise Elekta AB (publ)'s (STO:EKTA B) Earnings Pushing Shares 29% Higher
Elekta AB (publ) ( STO:EKTA B ) shareholders have had their patience rewarded with a 29% share price jump in the last...Analysis Article • Dec 05
Elekta's (STO:EKTA B) Soft Earnings Are Actually Better Than They Appear
Elekta AB (publ)'s ( STO:EKTA B ) stock was strong despite it releasing a soft earnings report last week. We think that...Narrative Update • Dec 02
EKTA B: Future Outlook Shows Balanced Risks With Expected China Sales Recovery
Analysts have increased their price target for Elekta from $53.79 to $56.77. This adjustment is based on improved forecasts for revenue growth and profit margin, along with a slightly higher estimated fair value.Analysis Article • Nov 15
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analysis Article • Oct 31
What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
Elekta AB (publ) ( STO:EKTA B ), might not be a large cap stock, but it received a lot of attention from a substantial...Analysis Article • Oct 06
Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend on the 11th of March, with...Analysis Article • Sep 15
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 11th...Narrative Update • Sep 02
AI-Powered Iris Technology Will Strengthen Future Prospects
Despite a modest improvement in consensus revenue growth forecasts, Elekta’s future P/E multiple has edged lower, contributing to a reduced consensus analyst price target from SEK57.79 to SEK55.31. What's in the News Elekta reiterated full-year sales growth guidance for 2025–2026 but expects continued near-term sales weakness in the US and lingering negative effects from prior low orders in China; FX and tariffs expected to pressure Q2 earnings, with hopes of Chinese sales recovery later in the year.Analysis Article • Aug 28
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 11th...Analysis Article • Aug 19
There's No Escaping Elekta AB (publ)'s (STO:EKTA B) Muted Revenues
You may think that with a price-to-sales (or "P/S") ratio of 1x Elekta AB (publ) ( STO:EKTA B ) is definitely a stock...Analysis Article • Aug 04
Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) will pay a dividend of SEK1.20 on the 11th of September. This means the annual payment...Analysis Article • Jul 25
Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • May 28
Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?
Elekta AB (publ) ( STO:EKTA B ), might not be a large cap stock, but it saw a double-digit share price rise of over 10...Analysis Article • Mar 19
Does Elekta (STO:EKTA B) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Narrative • Mar 16
AI-Powered Iris Technology Will Strengthen Future Prospects
Strong order growth and high book-to-bill ratio provide a solid foundation for future revenue and sales growth.Analysis Article • Feb 27
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 12th of March...Analysis Article • Feb 26
Earnings Miss: Elekta AB (publ) Missed EPS By 5.4% And Analysts Are Revising Their Forecasts
Last week, you might have seen that Elekta AB (publ) ( STO:EKTA B ) released its quarterly result to the market. The...Analysis Article • Feb 17
Potential Upside For Elekta AB (publ) (STO:EKTA B) Not Without Risk
With a median price-to-earnings (or "P/E") ratio of close to 24x in Sweden, you could be forgiven for feeling...Analysis Article • Feb 03
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 12th of March...Analysis Article • Jan 17
What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?
Elekta AB (publ) ( STO:EKTA B ), is not the largest company out there, but it received a lot of attention from a...Analysis Article • Dec 23
Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) will pay a dividend of SEK1.20 on the 12th of March. This means the annual payment is...Analysis Article • Nov 18
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 12th...Analysis Article • Nov 15
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysis Article • Nov 01
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend on the 12th of March, with...Analysis Article • Oct 09
Elekta AB (publ) (STO:EKTA B) Screens Well But There Might Be A Catch
There wouldn't be many who think Elekta AB (publ)'s ( STO:EKTA B ) price-to-earnings (or "P/E") ratio of 24.1x is worth...Analysis Article • Sep 24
Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
The board of Elekta AB (publ) ( STO:EKTA B ) has announced that it will pay a dividend of SEK1.20 per share on the 12th...Analysis Article • Sep 09
Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Elekta AB (publ) ( STO:EKTA B ) will pay a dividend of SEK1.20 on the 12th of March. This means the annual payment is...Shareholder Returns
| EKTA B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 3.1% | 1.5% | 0.4% |
| 1Y | 7.1% | -11.5% | 10.5% |
Return vs Industry: EKTA B exceeded the Swedish Medical Equipment industry which returned -10.8% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned 10.5% over the past year.
Price Volatility
| EKTA B volatility | |
|---|---|
| EKTA B Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.9% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: EKTA B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: EKTA B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 4,353 | Jakob Just-Bomholt | www.elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite.
Elekta AB (publ) Fundamentals Summary
| EKTA B fundamental statistics | |
|---|---|
| Market cap | SEK 20.75b |
| Earnings (TTM) | -SEK 519.00m |
| Revenue (TTM) | SEK 16.72b |
1.2x
P/S Ratio-40.0x
P/E RatioIs EKTA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKTA B income statement (TTM) | |
|---|---|
| Revenue | SEK 16.72b |
| Cost of Revenue | SEK 10.30b |
| Gross Profit | SEK 6.42b |
| Other Expenses | SEK 6.94b |
| Earnings | -SEK 519.00m |
Last Reported Earnings
Apr 30, 2026
Next Earnings Date
Jul 03, 2026
| Earnings per share (EPS) | -1.36 |
| Gross Margin | 38.38% |
| Net Profit Margin | -3.10% |
| Debt/Equity Ratio | 88.4% |
How did EKTA B perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield-177%
Payout RatioDoes EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarks| Elekta dividend dates | |
|---|---|
| Ex Dividend Date | Sep 04 2026 |
| Dividend Pay Date | Sep 10 2026 |
| Days until Ex dividend | 86 days |
| Days until Dividend pay date | 92 days |
Does EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/08 12:30 |
| End of Day Share Price | 2026/06/08 00:00 |
| Earnings | 2026/04/30 |
| Annual Earnings | 2026/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elekta AB (publ) is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Alexander Kleban | Barclays |
| Sally Taylor | Barclays |